279 related articles for article (PubMed ID: 32623334)
1. Brain Hepcidin Suppresses Major Pathologies in Experimental Parkinsonism.
Liang T; Qian ZM; Mu MD; Yung WH; Ke Y
iScience; 2020 Jul; 23(7):101284. PubMed ID: 32623334
[TBL] [Abstract][Full Text] [Related]
2. Hepcidin Decreases Rotenone-Induced α-Synuclein Accumulation
Li M; Hu J; Yuan X; Shen L; Zhu L; Luo Q
Front Mol Neurosci; 2020; 13():560891. PubMed ID: 33177988
[TBL] [Abstract][Full Text] [Related]
3. Iron as the concert master in the pathogenic orchestra playing in sporadic Parkinson's disease.
Riederer P; Monoranu C; Strobel S; Iordache T; Sian-Hülsmann J
J Neural Transm (Vienna); 2021 Oct; 128(10):1577-1598. PubMed ID: 34636961
[TBL] [Abstract][Full Text] [Related]
4. Hepcidin Plays a Key Role in 6-OHDA Induced Iron Overload and Apoptotic Cell Death in a Cell Culture Model of Parkinson's Disease.
Xu Q; Kanthasamy AG; Jin H; Reddy MB
Parkinsons Dis; 2016; 2016():8684130. PubMed ID: 27298749
[TBL] [Abstract][Full Text] [Related]
5. Neuropathology of sporadic Parkinson disease before the appearance of parkinsonism: preclinical Parkinson disease.
Ferrer I; Martinez A; Blanco R; Dalfó E; Carmona M
J Neural Transm (Vienna); 2011 May; 118(5):821-39. PubMed ID: 20862500
[TBL] [Abstract][Full Text] [Related]
6. Myrcene Salvages Rotenone-Induced Loss of Dopaminergic Neurons by Inhibiting Oxidative Stress, Inflammation, Apoptosis, and Autophagy.
Azimullah S; Jayaraj RL; Meeran MFN; Jalal FY; Adem A; Ojha S; Beiram R
Molecules; 2023 Jan; 28(2):. PubMed ID: 36677744
[TBL] [Abstract][Full Text] [Related]
7. Piperlongumine restores the balance of autophagy and apoptosis by increasing BCL2 phosphorylation in rotenone-induced Parkinson disease models.
Liu J; Liu W; Lu Y; Tian H; Duan C; Lu L; Gao G; Wu X; Wang X; Yang H
Autophagy; 2018; 14(5):845-861. PubMed ID: 29433359
[TBL] [Abstract][Full Text] [Related]
8. Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse.
Perfeito R; Cunha-Oliveira T; Rego AC
Free Radic Biol Med; 2013 Sep; 62():186-201. PubMed ID: 23743292
[TBL] [Abstract][Full Text] [Related]
9. Vinpocetine prevents rotenone-induced Parkinson disease motor and non-motor symptoms through attenuation of oxidative stress, neuroinflammation and α-synuclein expressions in rats.
Ishola IO; Awogbindin IO; Olubodun-Obadun TG; Olajiga AE; Adeyemi OO
Neurotoxicology; 2023 May; 96():37-52. PubMed ID: 36965781
[TBL] [Abstract][Full Text] [Related]
10. Autophagy protects the rotenone-induced cell death in alpha-synuclein overexpressing SH-SY5Y cells.
Dadakhujaev S; Noh HS; Jung EJ; Cha JY; Baek SM; Ha JH; Kim DR
Neurosci Lett; 2010 Mar; 472(1):47-52. PubMed ID: 20117172
[TBL] [Abstract][Full Text] [Related]
11. AMPK-dependent autophagy activation and alpha-Synuclein clearance: a putative mechanism behind alpha-mangostin's neuroprotection in a rotenone-induced mouse model of Parkinson's disease.
Parekh P; Sharma N; Sharma M; Gadepalli A; Sayyed AA; Chatterjee S; Kate A; Khairnar A
Metab Brain Dis; 2022 Dec; 37(8):2853-2870. PubMed ID: 36178640
[TBL] [Abstract][Full Text] [Related]
12. Effect of excess iron on oxidative stress and gluconeogenesis through hepcidin during mitochondrial dysfunction.
Lee HJ; Choi JS; Lee HJ; Kim WH; Park SI; Song J
J Nutr Biochem; 2015 Dec; 26(12):1414-23. PubMed ID: 26383538
[TBL] [Abstract][Full Text] [Related]
13. Rotenone induces regionally distinct α-synuclein protein aggregation and activation of glia prior to loss of dopaminergic neurons in C57Bl/6 mice.
Rocha SM; Bantle CM; Aboellail T; Chatterjee D; Smeyne RJ; Tjalkens RB
Neurobiol Dis; 2022 Jun; 167():105685. PubMed ID: 35257879
[TBL] [Abstract][Full Text] [Related]
14. Drp-1 dependent mitochondrial fragmentation and protective autophagy in dopaminergic SH-SY5Y cells overexpressing alpha-synuclein.
Martinez JH; Alaimo A; Gorojod RM; Porte Alcon S; Fuentes F; Coluccio Leskow F; Kotler ML
Mol Cell Neurosci; 2018 Apr; 88():107-117. PubMed ID: 29414102
[TBL] [Abstract][Full Text] [Related]
15. Translational molecular imaging and drug development in Parkinson's disease.
Haider A; Elghazawy NH; Dawoud A; Gebhard C; Wichmann T; Sippl W; Hoener M; Arenas E; Liang SH
Mol Neurodegener; 2023 Feb; 18(1):11. PubMed ID: 36759912
[TBL] [Abstract][Full Text] [Related]
16. Hepcidin Suppresses Brain Iron Accumulation by Downregulating Iron Transport Proteins in Iron-Overloaded Rats.
Du F; Qian ZM; Luo Q; Yung WH; Ke Y
Mol Neurobiol; 2015 Aug; 52(1):101-14. PubMed ID: 25115800
[TBL] [Abstract][Full Text] [Related]
17. Gene therapy of yeast NDI1 on mitochondrial complex I dysfunction in rotenone-induced Parkinson's disease models in vitro and vivo.
Li H; Sun B; Huang Y; Zhang J; Xu X; Shen Y; Chen Z; Yang J; Shen L; Hu Y; Gu H
Mol Med; 2022 Mar; 28(1):29. PubMed ID: 35255803
[TBL] [Abstract][Full Text] [Related]
18. Astrocyte hepcidin ameliorates neuronal loss through attenuating brain iron deposition and oxidative stress in APP/PS1 mice.
Xu Y; Zhang Y; Zhang JH; Han K; Zhang X; Bai X; You LH; Yu P; Shi Z; Chang YZ; Gao G
Free Radic Biol Med; 2020 Oct; 158():84-95. PubMed ID: 32707154
[TBL] [Abstract][Full Text] [Related]
19. Geraniol Protects Against the Protein and Oxidative Stress Induced by Rotenone in an In Vitro Model of Parkinson's Disease.
Rekha KR; Inmozhi Sivakamasundari R
Neurochem Res; 2018 Oct; 43(10):1947-1962. PubMed ID: 30141137
[TBL] [Abstract][Full Text] [Related]
20. Decreased serum hepcidin concentration correlates with brain iron deposition in patients with HBV-related cirrhosis.
Lin D; Ding J; Liu JY; He YF; Dai Z; Chen CZ; Cheng WZ; Zhou J; Wang X
PLoS One; 2013; 8(6):e65551. PubMed ID: 23776499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
